workflow:
  id: workflow_002
  title: Biotechnology Gene Therapy Manufacturing Scale-Up
  department: Biomanufacturing
  complexity: complex
  participants:
  - Process Engineers
  - Quality Control Scientists
  - Regulatory Affairs Specialists
  - Supply Chain Managers
  - Clinical Operations Team
  trigger: Phase 2 clinical trial data supports advancement to Phase 3 requiring increased
    production capacity
  steps:
  - step: 1
    actor: Process Engineers
    action: Scale production process from clinical to commercial manufacturing parameters
    tools:
    - Process simulation software
    - Scale-up modeling tools
    - Equipment specification documents
    duration: 2 weeks
    outputs:
    - Scaled process parameters
    - Equipment procurement requirements
  - step: 2
    actor: Quality Control Scientists
    action: Develop and validate analytical methods for commercial-scale quality testing
    decision_points:
    - Method sensitivity requirements
    - Regulatory acceptance criteria
    tools:
    - Analytical instrumentation
    - Validation protocols
    - Statistical analysis software
    duration: 3 weeks
    outputs:
    - Validated analytical methods
    - Quality control specifications
  - step: 3
    actor: Supply Chain Managers
    action: Secure raw material suppliers and establish supply chain for commercial
      production
    tools:
    - Supplier qualification system
    - Contract manufacturing databases
    - Risk assessment tools
    duration: 4 weeks
    outputs:
    - Qualified supplier agreements
    - Supply chain risk mitigation plan
  - step: 4
    actor: Regulatory Affairs Specialists
    action: Prepare and submit regulatory filings for commercial manufacturing changes
    decision_points:
    - Regulatory pathway requirements
    - Data package completeness
    tools:
    - Regulatory submission software
    - CMC documentation systems
    duration: 6 weeks
    outputs:
    - Regulatory submission package
    - Manufacturing authorization updates
  - step: 5
    actor: Clinical Operations Team
    action: Coordinate manufacturing timeline with clinical trial supply requirements
    tools:
    - Clinical supply planning software
    - Inventory management systems
    duration: 2 weeks
    outputs:
    - Integrated supply timeline
    - Contingency planning documentation
  success_criteria: Commercial-scale manufacturing process validated and regulatory
    approved for Phase 3 clinical supply
  failure_modes:
  - Process scale-up technical challenges
  - Supplier qualification delays
  - Regulatory review timeline extensions
  metrics:
  - 'Process yield improvement: Target >90% from clinical scale'
  - 'Quality control pass rate: Target >98% for commercial batches'
  - 'Regulatory approval timeline: Target <6 months from submission'
  - 'Cost per dose reduction: Target 30% from clinical manufacturing'
  - 'Supply chain reliability: Target >99% on-time delivery'
  - 'Scale-up efficiency: Target <15% timeline overrun'
